Pharmaceuticals and personal care products have raised significant concerns because of their extensive use, presence in aquatic environments, and potential impacts on wildlife and humans. Carbamazepine was the most frequently detected pharmaceutical residue among pharmaceuticals and personal care products. Nevertheless, the low removal efficiency of carbamazepine by conventional wastewater treatment plants was due to resistance to biodegradation at low concentrations. A membrane bioreactor (MBR) has recently attracted attention as a new separation process for wastewater treatment in cities and industries because of its effectiveness in separating pollutants and its tolerance to high or shock loadings. In the current research, the main and interaction effects of three operating parameters, including hydraulic retention time (12-24 h), dissolved oxygen (1.5-5.5 mg/L), and sludge retention time (5-15 days), on removing carbamazepine, chemical oxygen demand, ammonia nitrogen, and phosphorus using ceramic membranes was investigated by applying a two-level full-factorial design analysis. Optimum dissolved oxygen, hydraulic retention time, and sludge retention time were 1.7 mg/L, 24 h, and 5 days, respectively. The research results showed the applicability of the MBR to wastewater treatment with a high carbamazepine loading rate and the removal of nutrients.

This study analysed the kinetic results in the presence and absence of micropollutants (bisphenol A, carbamazepine, ciprofloxacin, and the mixture of the three compounds) obtained with respirometric tests with mixed liquor and heterotrophic biomass in a membrane bioreactor (MBR) working for two different hydraulic retention times (12-18 h) and under low-temperature conditions (5-8 °C). Independently of the temperature, the organic substrate was biodegraded faster over a longer hydraulic retention time (HRT) with similar doping, which was probably due to the longer contact time between the substrate and microorganisms within the bioreactor. However, low values of temperature negatively affected the net heterotrophic biomass growth rate, with reductions from 35.03 to 43.66% in phase 1 (12 h HRT) and from 37.18 to 42.77% in phase 2 (18 h HRT). The combined effect of the pharmaceuticals did not worsen the biomass yield compared with the effects caused individually.

Pharmaceutical and personal care products are frequently used in various fields and released into water bodies from the outlets of wastewater treatment plants. These products can harm the environment and human health even at low concentrations. Carbamazepine (CBZ), the most persistent pharmaceutical, has frequently been found in surface waters that bypassed the secondary treatments of conventional activated sludge. In addition, the treatment of phosphate in wastewater by the electrochemical process has recently attracted much attention because of its ability to remove, recover, and prevent environmental problems associated with eutrophication. This study proposes using the electrochemical process as an advanced oxidation process to simultaneously treat CBZ and phosphate from the moving-bed membrane bioreactor effluent. The study includes a long-term survey of CBZ treatment efficiency and common parameters of synthetic wastewater in the moving-bed membrane bioreactor system. Afterward, the electrochemical process is applied as an advanced oxidation process for the simultaneous removal of CBZ and phosphate from the moving-bed membrane bioreactor. Under the investigated conditions, CBZ has proven not to be an inhibitor of microbial activity, as evidenced by the high extent of chemical oxygen demand and nutrient removal. Using a factorial design, the electrochemical process using Pt/Ti as anode and cathode under optimal conditions (reaction time-80 min, bias potential-3 V, and electrode distance-1 cm) resulted in as high as 56.94% CBZ and 95.95% phosphate removal, respectively. The results demonstrated the ability to combine an electrochemical and a moving-bed membrane bioreactor process to simultaneously remove CBZ and phosphate in wastewater.

Recently, ozonation has been advocated as a solution to tackle emerging contaminants. Hollow fiber membrane contactors (HFMC) have a lower residual ozone concentration than bubble reactors that could limit the formation of potential ozonation by-products, especially bromates that are regulated in drinking water. The aim of this study was to evaluate ozonation with HFMC for pharmaceutical abatement and bromate minimization compared to bubble columns in wastewater. A HFMC, composed of 65 polytetrafluoroethylene hollow fibers with a 0.45 mm/0.87 mm inner/external diameter and a 0.107 m² exchange surface, was used for the ozonation of real-treated wastewater spiked with 2 µM of p-chlorobenzoic acid (p-CBA) and 3 mg.L-1 of bromide. p-CBA was tracked to monitor the production of strongly-oxidant hydroxyl radicals from the decomposition of the molecular ozone. At 100% p-CBA abatement, 1600 µg.L-1 of bromate was formed with the HFMC, whereas 3486 µg.L-1 was formed with the bubble column. These results demonstrate that HFMC can produce a significant amount of hydroxyl radicals while limiting bromate formation in real-treated wastewater. The test water was also spiked with carbamazepine and sulfamethoxazole to evaluate the abatement efficiency of the process. Short contact times (approximately 2s) achieved high rates of pharmaceuticals removal without bromate formation.

The removal of three emerging pollutants: carbamazepine, ketoprofen, and bisphenol A, has been studied using the nanofiltration flat sheet membrane NF99HF. The removal efficiencies of the membrane have been evaluated by two system characteristic parameters: permeate flux and rejection coefficient. The influence of two operating variables has been analysed: operating pressure and feed concentration. Before and after the tests with emerging pollutants, the membrane has been characterized by determining its water permeability coefficient and its magnesium chloride rejection coefficient to find out if the removal of emerging pollutants causes membrane fouling. The results show that operating pressure has significant separation effects, obtaining the highest efficiencies at a pressure of 20 bar for pollutant concentrations between 5 and 25 mg/L. Moreover, rejection of ketoprofen was found to be dependent on electrostatic repulsion, while rejection of bisphenol A was significantly affected by adsorption onto the membrane. Finally, the experimental data have been fitted to the solution diffusion model and to the simplified model of Spiegler-Kedem-Katchalsky to predict the behaviour of the nanofiltration membrane in the removal of the tested pollutants. Good agreement between the experimental and predicted carbamazepine and bisphenol A data has been obtained with each model, respectively.

This study in-situ modified a commercial nanofiltration membrane, NF90, through the concentration-polymerization-enhanced radical graft polarization method by applying two agents of 3-sulfopropyl methacrylate potassium salt (SPM) and 2-hydroxyethyl methacrylate (HEMA) with different dosages. Surface characterization revealed that the modified membranes became rougher and more hydrophilic compared with the pristine membrane. The modified membranes exhibited considerably enhanced separation performance with 5.8-19.6% higher NaCl rejection and 17.2-19.9% higher pharmaceuticals and personal care products (PPCPs) rejection than the pristine membrane. When treating the feedwater with high silica concentration, the modified membranes exhibited relatively less flux decline with high percentage of reversible fouling, especially the ones modified using a lower monomer concentration (0.01 M SPM and 0.01 M HEMA). Moreover, membrane modification enhanced the PPCP rejection (1.3-5.4%) after silica fouling by mitigating foulant deposition on the membrane surface. The fouling mechanism was confirmed to be intermediate blocking of membrane pores. Therefore, the in-situ modification technique with a low monomer concentration proved to be effective for mitigating silica fouling and improving PPCP rejection, which can be easily performed and cost-effective in practical application.

In this study, Ag and Pd bimetallic nanoparticles were generated in situ in polyethersulfone (PES) dope solutions, and membranes were fabricated through a phase inversion method. The membranes were characterized for various physical and chemical properties using techniques such as FTIR, SEM, AFM, TEM, EDS, and contact angle measurements. The membranes were then evaluated for their efficiency in rejecting EOCs and resistance to protein fouling. TEM micrographs showed uniform distribution of Ag/Pd nanoparticles within the PES matrix, while SEM images showed uniform, fingerlike structures that were not affected by the presence of embedded nanoparticles. The presence of Ag/Pd nanoparticles resulted in rougher membranes. There was an increase in membrane hydrophilicity with increasing nanoparticles loading, which resulted in improved pure water permeability (37−135 Lm2h−1bar−1). The membranes exhibited poor salt rejection (<15%), making them less susceptible to flux decline due to concentration polarization. With a mean pore radius of 2.39−4.70 nm, the membranes effectively removed carbamazepine, caffeine, sulfamethoxazole, ibuprofen, and naproxen (up to 40%), with size exclusion being the major removal mechanism. Modifying the membranes with Ag/Pd nanoparticles improved their antifouling properties, making them a promising innovation for the treatment of pharmaceutical wastewater.

Despite pharmaceuticals being widely detected in water-bodies worldwide, what remain unclear are the effects of high pharmaceutical concentrations on the treatment efficiency of biological wastewater treatment processes, such as membrane bioreactor (MBR) systems. This study investigated the efficiency of MBR technology in the treatment of synthetic wastewater containing a mixture of five typical pharmaceuticals (ofloxacin, sulfamethoxazole, sulfamethylthiadiazole, carbamazepine and naproxen) with a total concentration of 500 µg/L. Both the control MBR (MBRc) without pharmaceutical dosing and the MBR operated with high influent pharmaceutical concentrations (MBRe) were operated under room temperature with the same hydraulic retention time of 11 h and the same sludge retention time of 30 d. The removal efficiency rates of total nitrogen and total phosphorus were 83.2% vs. 90.1% and 72.6% vs. 57.8% in the MBRc vs. MBRe systems, and both MBRs achieved >98% removal of organics for a 180-day period. The floc size decreased, and membrane fouling became more severe in the MBRe system. Microbial diversity increased in the MBRe system and the relative abundances of functional microbe differed between the two MBRs. Furthermore, the total relative abundances of genes involved in glycolysis, assimilating nitrate reduction and nitrification processes increased in the MBRe system, which could account for the higher organics and nitrogen removal performance. This work provides insights for MBR operation in wastewater treatment with high pharmaceutical concentrations.